----------------------- Advertisement --------------------------
Survey

The Superbug and India?

According to a study published in The Lancet Infectious Diseases, one of the world’s major medical journals, researchers claim that a group of bacteria called Enterobacteriaceae (commonly found in the gut), have developed, probably because of the overuse of antibiotics, resistance to highly effective drugs like the carbapenems. This is because they are able to produce an enzyme called New Delhi metallo-beta-lactamase-1 (NDM-1) which renders these drugs ineffective. The researchers suggest that this phenomenon of carbapenem resistance has the potential to become a major global health problem. They also suggest that as these bacteria were first isolated from a patient who had recently been in New Delhi they strongly advise UK patients against coming to India for surgery.

What is your opinion on this report?

 
Q. Do you think the authors are correct and it should be a warning to doctors not to misuse antibiotics?

70.20%
Yes

24.60%
No

5.30%
Can't Say
YesNoCan't Say
 
Q. Do you think the international community is discrediting Indian healthcare?

74.60%
Yes

20.20%
No

5.30%
Can't Say
YesNoCan't Say
Q. Will it affect medical tourism India?

56.10%
Yes

36.80%
No

7.00%
Can't Say
YesNoCan't Say
 
Q. Do you think that our media has sensationalised the issue?

64.30%
Yes

30.40%
No

5.40%
Can't Say
YesNoCan't Say
Q. Do you think NDM-1 really originated in India?

14.90%
Yes

47.40%
No

37.70%
Can't Say
YesNoCan't Say
 
Q. Do you think naming the ‘superbug’ New Delhi metallo-beta-lactamase-1 (NDM-1) is inappropriate?

61.20%
Yes

23.30%
No

15.50%
Can't Say
YesNoCan't Say
 
Previous Survey
----------------------- Advertisement4 --------------------------
 
Latest Photos
 
 
-------------------------------- Advertisement -----------------------------------